Your browser doesn't support javascript.
loading
Efficacy and safety results from a phase 1b/2, multicenter, open-label study of oprozomib and dexamethasone in patients with relapsed and/or refractory multiple myeloma.
Hari, Parameswaran; Paba-Prada, Claudia E; Voorhees, Peter M; Frye, John; Chang, Yu-Lin; Moreau, Philippe; Zonder, Jeffrey; Boccia, Ralph; Shain, Kenneth H.
Afiliação
  • Hari P; Medical College of Wisconsin, Milwaukee, WI, USA. Electronic address: phari@mcw.edu.
  • Paba-Prada CE; Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: ClaudiaPab@baptisthealth.net.
  • Voorhees PM; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA. Electronic address: peter.voorhees@atriumhealth.org.
  • Frye J; Onyx Pharmaceuticals, Inc., an Amgen subsidiary, South San Francisco, CA, USA. Electronic address: giovanni@sbcglobal.net.
  • Chang YL; Onyx Pharmaceuticals, Inc., an Amgen subsidiary, South San Francisco, CA, USA. Electronic address: cylchang@gmail.com.
  • Moreau P; University Hospital, Nantes, France. Electronic address: philippe.moreau@chu-nantes.fr.
  • Zonder J; Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA. Electronic address: zonderj@karmanos.org.
  • Boccia R; Center for Cancer and Blood Disorders, Bethesda, MD, USA. Electronic address: rboccia@ccbdmd.com.
  • Shain KH; Moffitt Cancer Center, Tampa, FL, USA. Electronic address: ken.shain@moffitt.org.
Leuk Res ; 83: 106172, 2019 08.
Article em En | MEDLINE | ID: mdl-31229804

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Tipo de estudo: Clinical_trials Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Tipo de estudo: Clinical_trials Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article